PODCASTS

SCOTUS ruling on FDA “Mail-Order Mifepristone” – 6/24/24

SCOTUS ruling on FDA “Mail-Order Mifepristone” – 6/24/24

A Special Family Life Interview

The U.S. Supreme Court, at least temporarily, has allowed continued mail-order distribution of abortion-inducing pills. A group of pro-life physicians had sued to stop the practice, after FDA regulations were revised to eliminate a requirement to meet with a doctor before starting the process to end the pregnancy. The latest FDA rules say even a video visit with a prescriber is no longer needed.

Opponents of widespread use of the two-pill “cocktail” of Mifepristone and Misoprostal quote the FDA’s own statistics that 1 of every 25 women who take these drugs end up in an emergency department with complications. Other physical and emotional-health consequences are likely more numerous.

Attorney Katie Daniel of Susan B. Anthony Pro-Life America gave Family Life News her reaction to the SCOTUS decision, predictions on where the case goes next, and why these pills can be so harmful to women, especially with no required followup with a medical professional.

 

For further information:

  • More from Katie Daniel: In-depth polling, conducted by CRC Research for Susan B. Anthony Pro-Life America, reveals that 75% of Americans believe the FDA should have performed studies focused on girls under the age of 18 before approving these pills for minors.
  • Susan B. Anthony Pro-Life America: That organizations official website
  • SBA on WPLG: Women’s safety, in light of sexual trafficking and domestic abusers
  • Click the picture of the Court building to read the full June 13 decision.
Comments are closed.

EMAIL FAMILY LIFE

Fill out my online form.